These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 19201174

  • 1. Myeloperoxidase and paraoxonase-1 in type 2 diabetic patients.
    Jornayvaz FR, Brulhart-Meynet MC, James RW.
    Nutr Metab Cardiovasc Dis; 2009 Nov; 19(9):613-9. PubMed ID: 19201174
    [Abstract] [Full Text] [Related]

  • 2. Postprandial modulation of serum paraoxonase activity and concentration in diabetic and non-diabetic subjects.
    Beer S, Moren X, Ruiz J, James RW.
    Nutr Metab Cardiovasc Dis; 2006 Oct; 16(7):457-65. PubMed ID: 17015182
    [Abstract] [Full Text] [Related]

  • 3. High plasma C-reactive protein (CRP) is related to low paraoxonase-I (PON-I) activity independently of high leptin and low adiponectin in type 2 diabetes mellitus.
    Dullaart RP, de Vries R, Sluiter WJ, Voorbij HA.
    Clin Endocrinol (Oxf); 2009 Feb; 70(2):221-6. PubMed ID: 18505467
    [Abstract] [Full Text] [Related]

  • 4. Inverse correlation of serum paraoxonase and homocysteine thiolactonase activities and antioxidant capacity of high-density lipoprotein with the severity of cardiovascular disease in persons with type 2 diabetes mellitus.
    Lakshman MR, Gottipati CS, Narasimhan SJ, Munoz J, Marmillot P, Nylen ES.
    Metabolism; 2006 Sep; 55(9):1201-6. PubMed ID: 16919539
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Smoking is associated with reduced serum levels of the antioxidant enzyme, paraoxonase, in Type 2 diabetic patients.
    Boemi M, Sirolla C, Testa R, Cenerelli S, Fumelli P, James RW.
    Diabet Med; 2004 May; 21(5):423-7. PubMed ID: 15089785
    [Abstract] [Full Text] [Related]

  • 8. High-density lipoprotein composition and paraoxonase activity in Type I diabetes.
    Valabhji J, McColl AJ, Schachter M, Dhanjil S, Richmond W, Elkeles RS.
    Clin Sci (Lond); 2001 Dec; 101(6):659-70. PubMed ID: 11724654
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Hormone-replacement therapy increases serum paraoxonase arylesterase activity in diabetic postmenopausal women.
    Sutherland WH, Manning PJ, de Jong SA, Allum AR, Jones SD, Williams SM.
    Metabolism; 2001 Mar; 50(3):319-24. PubMed ID: 11230785
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Gender-specific correlation between plasma myeloperoxidase levels and serum high-density lipoprotein-associated paraoxonase-1 levels in patients with stable and unstable coronary artery disease.
    Yunoki K, Naruko T, Inaba M, Inoue T, Nakagawa M, Sugioka K, Ohsawa M, Iwasa Y, Komatsu R, Itoh A, Haze K, Yoshiyama M, Becker AE, Ueda M.
    Atherosclerosis; 2013 Dec; 231(2):308-14. PubMed ID: 24267244
    [Abstract] [Full Text] [Related]

  • 15. Paraoxonase/arylesterase in serum of patients with type II diabetes mellitus.
    Juretić D, Motejlkova A, Kunović B, Rekić B, Flegar-Mestrić Z, Vujić L, Mesić R, Lukac-Bajalo J, Simeon-Rudolf V.
    Acta Pharm; 2006 Mar; 56(1):59-68. PubMed ID: 16613735
    [Abstract] [Full Text] [Related]

  • 16. Protective effect of paraoxonase 1 of high-density lipoprotein in type 2 diabetic patients with nephropathy.
    Li C, Gu Q.
    Nephrology (Carlton); 2009 Aug; 14(5):514-20. PubMed ID: 19207863
    [Abstract] [Full Text] [Related]

  • 17. Gemfibrozil increases paraoxonase activity in type 2 diabetic patients. A new hypothesis of the beneficial action of fibrates?
    Balogh Z, Seres I, Harangi M, Kovács P, Kakuk G, Paragh G.
    Diabetes Metab; 2001 Nov; 27(5 Pt 1):604-10. PubMed ID: 11694861
    [Abstract] [Full Text] [Related]

  • 18. Defective metabolism of oxidized phospholipid by HDL from people with type 2 diabetes.
    Mastorikou M, Mackness M, Mackness B.
    Diabetes; 2006 Nov; 55(11):3099-103. PubMed ID: 17065348
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Oxidation of apolipoprotein B-containing lipoproteins and serum paraoxonase/arylesterase activities in major depressive disorder.
    Sarandol A, Sarandol E, Eker SS, Karaagac EU, Hizli BZ, Dirican M, Kirli S.
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug 30; 30(6):1103-8. PubMed ID: 16716479
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.